We are live on ! Find out more
CIM

Contravisory Investment Management Portfolio holdings

AUM $566M
1-Year Est. Return 42.93%
This Fund
S&P 500
This Quarter Est. Return
+1.92%
1 Year Est. Return
+42.93%
3 Year Est. Return
+129.34%
5 Year Est. Return
+198.47%
10 Year Est. Return
+603.03%
AUM
$343M
AUM Growth
-$33M
Cap. Flow
-$39.8M
Cap. Flow %
-11.62%
Top 10 Hldgs %
29.36%
Holding
249
New
44
Increased
30
Reduced
59
Closed
53

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$13M
2
HUM icon
Humana
HUM
+$12.9M
3
MCO icon
Moody's
MCO
+$12M
4
BRCM
BROADCOM CORP CL-A
BRCM
+$10.9M
5
CVS icon
CVS Health
CVS
+$10.8M

Sector Composition

Rank Sector Weight
1 Consumer Staples 21.59%
2 Financials 12.14%
3 Consumer Discretionary 11.15%
4 Technology 9.91%
5 Healthcare 9.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAC icon
201
Bank of America
BAC
$442B
-123
Closed -$2K
C icon
202
Citigroup
C
$226B
-38
Closed -$2K
COF icon
203
Capital One
COF
$134B
-27
Closed -$2K
CRI icon
204
Carter's
CRI
$1.47B
-2,155
Closed -$192K
CSCO icon
205
Cisco
CSCO
$479B
-70
Closed -$2K
CVS icon
206
CVS Health
CVS
$122B
-110,792
Closed -$10.8M
ELV icon
207
Elevance Health
ELV
$85.5B
-14
Closed -$2K
FHN icon
208
First Horizon
FHN
$12.1B
-14,167
Closed -$206K
GILD icon
209
Gilead Sciences
GILD
$165B
-128,713
Closed -$13M
GS icon
210
Goldman Sachs
GS
$303B
-11
Closed -$2K
HUM icon
211
Humana
HUM
$46.2B
-72,285
Closed -$12.9M
ITGR icon
212
Integer Holdings
ITGR
$4.26B
-3,951
Closed -$189K
KBE icon
213
State Street SPDR S&P Bank ETF
KBE
$1.66B
-43,292
Closed -$1.46M
KRE icon
214
State Street SPDR S&P Regional Banking ETF
KRE
$4.64B
-7,036
Closed -$295K
MCO icon
215
Moody's
MCO
$82.7B
-119,730
Closed -$12M
MDY icon
216
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.3B
-2,407
Closed -$611K
MET icon
217
MetLife
MET
$62.1B
-46
Closed -$2K
MIDD icon
218
Middleby
MIDD
$6.08B
-64,960
Closed -$7.01M
MSTR icon
219
Strategy Inc
MSTR
$38.4B
-11,090
Closed -$199K
MTH icon
220
Meritage Homes
MTH
$4.86B
-6,792
Closed -$115K
NOW icon
221
ServiceNow
NOW
$129B
-411,590
Closed -$7.13M
NVS icon
222
Novartis
NVS
$297B
-90
Closed -$7K
PZZA icon
223
Papa John's
PZZA
$806M
-91,047
Closed -$5.09M
QQQ icon
224
Invesco QQQ Trust
QQQ
$484B
-51,000
Closed -$5.71M
REGN icon
225
Regeneron Pharmaceuticals
REGN
$80.8B
-4
Closed -$2K

Similar funds

Contravisory Investment Management's Q1 2016 Portfolio in Review

As of Q1 2016, Contravisory Investment Management held 249 positions worth $343M, down 8.8% from $376M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Contravisory Investment Management withdrew a net $39.8M in Q1 2016, closing 53 positions and reducing 59 holdings. Its most notable exit was Gilead Sciences, an estimated $13M position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 22% of assets, up from 12% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Contravisory Investment Management opened a new position in Carnival Corporation Ltd worth $8.59M.

  • Contravisory Investment Management's largest Q1 2016 buy was Carnival Corporation Ltd: 162,817 shares worth $8.59M.
  • Contravisory Investment Management added most to General Mills in Q1 2016, an estimated $9.06M increase.
  • Contravisory Investment Management's biggest Q1 2016 reduction was Bank of New York Mellon, cutting an estimated $1.05M.
  • Contravisory Investment Management fully exited Gilead Sciences in Q1 2016, selling an estimated $13M.
  • Contravisory Investment Management's ten largest holdings make up 29% of its $343M portfolio in Q1 2016.
  • Contravisory Investment Management opened 44 new positions and closed 53 in Q1 2016.
  • Contravisory Investment Management's portfolio value fell 8.8% quarter-over-quarter to $343M.

Based on Contravisory Investment Management's 13F filing for Q1 2016, filed 11 Apr 2016.